{"Title": ["ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch", "ATRA Abuzz, ATOS' COVID-19 Med Effective, INO And VXRT On Track", "Atara Biotherapeutics Inc (ATRA) Q1 2020 Earnings Call Transcript", "2 Top Biotech Stocks Under $10", "Stock To Watch: Atara Biotherapeutics (ATRA)", "Tuesday's ETF Movers: REM, IBB", "Tuesday Sector Laggards: Biotechnology, Shipping Stocks", "Atara Biotherapeutics Inc (ATRA) Q4 2019 Earnings Call Transcript", "ARGX Soars On ADAPT Trial Data, MRK's Deals & Collaborations To Fight COVID-19, ALNY ON Watch", "2 Incredibly Cheap Cancer Stocks to Buy Now", "Atara Biotherapeutics Inc (ATRA) Q3 2019 Earnings Call Transcript", "Atara Biotherapeutics, Inc. (ATRA) Q2 2019 Earnings Call Transcript", "Health Care Sector Update for 07/19/2019: MTP, ATRA, IFRX, JNJ, ABT, MRK, PFE, AMGN", "Why Atara Biotherapeutics Has Slumped in 2019", "The Implied Analyst 12-Month Target For VBK", "Notable Thursday Option Activity: OXY, ATRA, SPWR", "Stock To Watch: Atara Biotherapeutics (ATRA)", "2 Best Biotech Buyout Plays", "Notable Tuesday Option Activity: RDC, ATRA, DAL", "Notable Tuesday Option Activity: RDC, ATRA, DAL", "Notable Two Hundred Day Moving Average Cross - ATRA", "Company News For Jan 4, 2019", "Why Delta Air Lines, Atara Biotherapeutics, and Skyworks Solutions Slumped Today", "ATRA Makes Bullish Cross Above Critical Moving Average", "Where Will Gilead Sciences Spend Its Cash?", "Atara Biotherapeutics Breaks Below 200-Day Moving Average - Notable for ATRA", "Atara Biotherapeutics (ATRA) in Focus: Stock Moves 6.9% Higher", "Pre-Market Most Active for Sep 12, 2018 : NLY, LC, FOMX, SNAP, ATRA, MU, AZN, WEN, TLRY, PEG, PRGS, WM", "ATRA Crosses Below Key Moving Average Level", "2 High-Flying Biotech Stocks With Even More Room to Grow", "3 Small-Cap Biotech Stocks to Keep on Your Radar", "Interesting ATRA Put And Call Options For July 20th", "Commit To Purchase Atara Biotherapeutics At $25, Earn 17.8% Annualized Using Options", "Atara Biotherapeutics Breaks Below 200-Day Moving Average - Notable for ATRA", "Atara Biotherapeutics (ATRA) in Focus: Stock Moves 6.9% Higher", "Is a Beat in the Cards for Celldex (CLDX) in Q4 Earnings?", "Health Care Sector Update for 03/01/2018: NVAX,ALKS,ATRA", "Biotech Crushing the Market: Best ETFs & Stocks YTD", "What's in Store for Epizyme (EPZM) This Earnings Season?", "Madrigal (MDGL) Q4 Earnings: What's in Store for the Stock?", "3 Top Growth Stocks to Buy Right Now", "Is a Beat in Store for Adverum (ADVM) This Earnings Season?", "What's in the Cards for Immune Design (IMDZ) in Q4 Earnings?", "What's in Store for Intrexon (XON) This Earnings Season?", "Is a Beat in Store for Horizon Pharma (HZNP) in Q4 Earnings?", "What's in the Cards for Merrimack (MACK) in Q4 Earnings?", "What's in Store for Endocyte (ECYT) This Earnings Season?", "What's in the Cards for Ionis (IONS) This Earnings Season?", "What's in the Cards for Puma (PBYI) This Earnings Season?", "Will ACADIA (ACAD) Disappoint Investors in Q4 Earnings?", "5 Best-Performing Stocks of the Top ETF of January", "3 Biotech Stocks With Jaw-Dropping Growth Potential", "Zacks.com highlights: Arbor Realty Trust, Simpson Manufacturing and Atara Biotherapeutics", "3 Stocks in Focus on New Analyst Coverage", "Atara Biotherapeutics Joins Elite Club Of Stocks With RS Ratings Over 90", "Why SandRidge Energy, Atara Biotherapeutics, and Hovnanian Enterprises Jumped Today", "Jazz Pharmaceuticals (JAZZ) Q4 Earnings: What to Expect?", "Will ACADIA (ACAD) Disappoint Investors in Q4 Earnings?", "A Recent History of Tax Reform: It Doesn't Always Go As Planned", "Health Care Sector Update for 09/05/2017: ATRA", "Tuesday's ETF Movers: XBI, GDXJ", "Atara Biotherapeutics (ATRA): Moving Average Crossover Alert", "What Falling Estimates & Price Mean for Atara Biotherapeutics (ATRA)", "Health Care Sector Update for 12/29/2017: ATRA,PGNX,AVDL", "Health Care Sector Update for 06/23/2016: BSPM, OGEN, ATRA", "Health Care Sector Update for 06/23/2016: CLRB,OGEN,ATRA", "Celsion (CLSN) Provides Pipeline Update, GEN-1 in Focus", "Aegerion Announces Reduction in Workforce to Cut Costs", "New Strong Buy Stocks for February 11th", "Dr. Reddy's Q3 Earnings Up Y/Y, Warning Letter in Focus", "Novo Nordisk Posts In Line Q4 Earnings, Tops Revenues", "Health Care Sector Update for 10/18/2016: ATRA", "Qiagen Q4 and 2015 Preliminary Results Dim; Shares Tank 13%", "Halozyme Therapeutics (HALO) in Focus: Stock Tumbles 16.7%", "Genomic Health Down on Bleak Preliminary Q4, '15 Results", "Myriad Genetics: Urologic Cancer Assays Positive in Trials", "Qiagen: Competition, Currency Headwind Play Spoilsport in Q3", "Atara Biotherapeutics (ATRA) Jumps: Stock Moves Up 6%", "Atara Plunges on Poor Results from Phase II PINTA 745 Study", "Bio-Techne (TECH) Q2 Earnings Match, Sales Beat Estimates", "Qiagen Q4 and 2015 Preliminary Results Dim; Shares Tank 13%", "Atara Biotherapeutics (ATRA) Jumps: Stock Moves Up 10%", "Health Care Sector Update for 10/20/2015: IMMY, RXII, ATRA", "Health Care Sector Update for 07/10/2015: ATRA, TXMD, WX", "Health Care Sector Update for 07/10/2015: ATRA, TXMD, WX", "Atara Biotherapeutics (ATRA) Crumbles: Stock Plunges 14.6% - Tale of the Tape", "Why Atara Biotherapeutics Inc. Shares Are Getting Mauled Today", "Friday Sector Laggards: Consumer Services, Biotechnology Stocks", "Seth Klarman Buys Stake in 3 Pharmaceutical Firms", "Model Portfolio Review - February 16, 2015", "Health Care Sector Update for 02/10/2015: ATRA,WMGI,BIOC", "Billion dollar biotech: FibroGen sets terms for $124 million IPO", "Atara Biotherapeutics prices IPO at $11, below the range", "Atara Biotherapeutics refiles terms for $75 million IPO", "Atara Biotherapeutics (ATRA) in Focus: Stock Rises 17.1% - Tale of the Tape", "14 US IPOs planned for the week of Jul 21", "Muscle loss biotech Atara Biotherapeutics sets terms for $75 million IPO", "US IPO Pricing Recap: 15 IPOs in the most active week since 2007; 66% ended at or below IPO price"], "Elapsed Time": ["MAY 26, 2020", "MAY 21, 2020", "MAY 7, 2020", "APR 27, 2020", "APR 23, 2020", "APR 7, 2020", "APR 7, 2020", "FEB 27, 2020", "MAY 26, 2020", "JAN 30, 2020", "NOV 8, 2019", "AUG 8, 2019", "JUL 19, 2019", "JUL 9, 2019", "MAY 24, 2019", "MAY 9, 2019", "FEB 11, 2020", "APR 23, 2019", "APR 9, 2019", "APR 9, 2019", "FEB 26, 2019", "JAN 4, 2019", "JAN 3, 2019", "NOV 29, 2018", "MAY 7, 2019", "OCT 8, 2018", "SEP 26, 2018", "SEP 12, 2018", "AUG 17, 2018", "JUN 20, 2018", "JUN 20, 2018", "JUN 5, 2018", "NOV 20, 2018", "OCT 8, 2018", "MAR 1, 2018", "MAR 1, 2018", "MAR 1, 2018", "FEB 27, 2018", "FEB 27, 2018", "FEB 26, 2018", "JUN 3, 2018", "FEB 26, 2018", "FEB 26, 2018", "FEB 26, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 23, 2018", "FEB 22, 2018", "FEB 26, 2018", "FEB 20, 2018", "JAN 31, 2018", "JAN 28, 2018", "JAN 16, 2018", "JAN 15, 2018", "JAN 12, 2018", "DEC 29, 2017", "FEB 21, 2018", "FEB 20, 2018", "NOV 1, 2017", "SEP 5, 2017", "APR 25, 2017", "NOV 2, 2016", "OCT 27, 2016", "DEC 29, 2017", "JUN 23, 2016", "JUN 23, 2016", "FEB 15, 2016", "FEB 12, 2016", "FEB 11, 2016", "FEB 10, 2016", "FEB 4, 2016", "OCT 18, 2016", "JAN 13, 2016", "JAN 12, 2016", "JAN 11, 2016", "JAN 8, 2016", "JAN 6, 2016", "DEC 21, 2015", "DEC 15, 2015", "FEB 3, 2016", "JAN 13, 2016", "OCT 29, 2015", "OCT 20, 2015", "JUL 10, 2015", "JUL 10, 2015", "JUL 2, 2015", "DEC 14, 2015", "FEB 27, 2015", "FEB 17, 2015", "FEB 16, 2015", "FEB 10, 2015", "OCT 30, 2014", "OCT 16, 2014", "OCT 7, 2014", "JUN 16, 2015", "JUL 21, 2014", "JUL 10, 2014", "AUG 1, 2014"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/argx-soars-on-adapt-trial-data-mrks-deals-collaborations-to-fight-covid-19-alny-on-watch", "https://www.nasdaq.com/articles/atra-abuzz-atos-covid-19-med-effective-ino-and-vxrt-on-track-2020-05-21", "https://www.nasdaq.com/articles/atara-biotherapeutics-inc-atra-q1-2020-earnings-call-transcript-2020-05-07", "https://www.nasdaq.com/articles/2-top-biotech-stocks-under-%2410-2020-04-27", "https://www.nasdaq.com/articles/stock-to-watch%3A-atara-biotherapeutics-atra-2020-04-23", "https://www.nasdaq.com/articles/tuesdays-etf-movers%3A-rem-ibb-2020-04-07", "https://www.nasdaq.com/articles/tuesday-sector-laggards%3A-biotechnology-shipping-stocks-2020-04-07", "https://www.nasdaq.com/articles/atara-biotherapeutics-inc-atra-q4-2019-earnings-call-transcript-2020-02-27", "https://www.nasdaq.com/articles/argx-soars-on-adapt-trial-data-mrks-deals-collaborations-to-fight-covid-19-alny-on-watch", "https://www.nasdaq.com/articles/2-incredibly-cheap-cancer-stocks-to-buy-now-2020-01-30", "https://www.nasdaq.com/articles/atara-biotherapeutics-inc-atra-q3-2019-earnings-call-transcript-2019-11-08", "https://www.nasdaq.com/articles/atara-biotherapeutics-inc.-atra-q2-2019-earnings-call-transcript-2019-08-08", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-19-2019%3A-mtp-atra-ifrx-jnj-abt-mrk-pfe-amgn-2019-07-19", "https://www.nasdaq.com/articles/why-atara-biotherapeutics-has-slumped-in-2019-2019-07-09", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-vbk-2019-05-24", "https://www.nasdaq.com/articles/notable-thursday-option-activity%3A-oxy-atra-spwr-2019-05-09", "https://www.nasdaq.com/articles/stock-to-watch%3A-atara-biotherapeutics-atra-2020-02-11", "https://www.nasdaq.com/articles/2-best-biotech-buyout-plays-2019-04-23", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-rdc-atra-dal-2019-04-09", "https://www.nasdaq.com/articles/notable-tuesday-option-activity-rdc-atra-dal-2019-04-09-0", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-atra-2019-02-26", "https://www.nasdaq.com/articles/company-news-for-jan-4-2019-2019-01-04", "https://www.nasdaq.com/articles/why-delta-air-lines-atara-biotherapeutics-and-skyworks-solutions-slumped-today-2019-01-03", "https://www.nasdaq.com/articles/atra-makes-bullish-cross-above-critical-moving-average-2018-11-29", "https://www.nasdaq.com/articles/where-will-gilead-sciences-spend-its-cash-2019-05-07", "https://www.nasdaq.com/articles/atara-biotherapeutics-breaks-below-200-day-moving-average-notable-atra-2018-10-08", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra-in-focus%3A-stock-moves-6.9-higher-2018-09-26", "https://www.nasdaq.com/articles/pre-market-most-active-sep-12-2018-nly-lc-fomx-snap-atra-mu-azn-wen-tlry-peg-prgs-wm-2018", "https://www.nasdaq.com/articles/atra-crosses-below-key-moving-average-level-2018-08-17", "https://www.nasdaq.com/articles/2-high-flying-biotech-stocks-even-more-room-grow-2018-06-20", "https://www.nasdaq.com/articles/3-small-cap-biotech-stocks-keep-your-radar-2018-06-20", "https://www.nasdaq.com/articles/interesting-atra-put-and-call-options-july-20th-2018-06-05", "https://www.nasdaq.com/articles/commit-purchase-atara-biotherapeutics-25-earn-178-annualized-using-options-2018-11-20", "https://www.nasdaq.com/articles/atara-biotherapeutics-breaks-below-200-day-moving-average-notable-atra-2018-10-08", "https://www.nasdaq.com/articles/health-care-sector-update-03012018-nvax-atra-icad-alks-2018-03-01", "https://www.nasdaq.com/articles/is-a-beat-in-the-cards-for-celldex-cldx-in-q4-earnings-2018-03-01", "https://www.nasdaq.com/articles/health-care-sector-update-03012018-nvaxalksatra-2018-03-01", "https://www.nasdaq.com/articles/biotech-crushing-market-best-etfs-stocks-ytd-2018-02-27", "https://www.nasdaq.com/articles/whats-in-store-for-epizyme-epzm-this-earnings-season-2018-02-27", "https://www.nasdaq.com/articles/madrigal-mdgl-q4-earnings%3A-whats-in-store-for-the-stock-2018-02-26", "https://www.nasdaq.com/articles/3-top-growth-stocks-buy-right-now-2018-06-03", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-adverum-advm-this-earnings-season-2018-02-26", "https://www.nasdaq.com/articles/whats-in-the-cards-for-immune-design-imdz-in-q4-earnings-2018-02-26", "https://www.nasdaq.com/articles/whats-in-store-for-intrexon-xon-this-earnings-season-2018-02-26", "https://www.nasdaq.com/articles/is-a-beat-in-store-for-horizon-pharma-hznp-in-q4-earnings-2018-02-23", "https://www.nasdaq.com/articles/whats-in-the-cards-for-merrimack-mack-in-q4-earnings-2018-02-23", "https://www.nasdaq.com/articles/whats-in-store-for-endocyte-ecyt-this-earnings-season-2018-02-23", "https://www.nasdaq.com/articles/whats-in-the-cards-for-ionis-ions-this-earnings-season-2018-02-22", "https://www.nasdaq.com/articles/whats-in-the-cards-for-puma-pbyi-this-earnings-season-2018-02-26", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q4-earnings-2018-02-20", "https://www.nasdaq.com/articles/5-best-performing-stocks-top-etf-january-2018-01-31", "https://www.nasdaq.com/articles/3-biotech-stocks-jaw-dropping-growth-potential-2018-01-28", "https://www.nasdaq.com/articles/zacks.com-highlights%3A-arbor-realty-trust-simpson-manufacturing-and-atara-biotherapeutics", "https://www.nasdaq.com/articles/3-stocks-in-focus-on-new-analyst-coverage-2018-01-15", "https://www.nasdaq.com/articles/atara-biotherapeutics-joins-elite-club-stocks-rs-ratings-over-90-2018-01-12", "https://www.nasdaq.com/articles/why-sandridge-energy-atara-biotherapeutics-and-hovnanian-enterprises-jumped-today-2017-12", "https://www.nasdaq.com/articles/jazz-pharmaceuticals-jazz-q4-earnings%3A-what-to-expect-2018-02-21", "https://www.nasdaq.com/articles/will-acadia-acad-disappoint-investors-in-q4-earnings-2018-02-20", "https://www.nasdaq.com/articles/recent-history-tax-reform-it-doesnt-always-go-planned-2017-11-01", "https://www.nasdaq.com/articles/health-care-sector-update-09052017-atra-2017-09-05", "https://www.nasdaq.com/articles/tuesdays-etf-movers-xbi-gdxj-2017-04-25", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra%3A-moving-average-crossover-alert-2016-11-02", "https://www.nasdaq.com/articles/what-falling-estimates-price-mean-for-atara-biotherapeutics-atra-2016-10-27", "https://www.nasdaq.com/articles/health-care-sector-update-12292017-atrapgnxavdl-2017-12-29", "https://www.nasdaq.com/articles/health-care-sector-update-06232016-bspm-ogen-atra-2016-06-23", "https://www.nasdaq.com/articles/health-care-sector-update-06232016-clrbogenatra-2016-06-23", "https://www.nasdaq.com/articles/celsion-clsn-provides-pipeline-update-gen-1-in-focus-2016-02-15", "https://www.nasdaq.com/articles/aegerion-announces-reduction-in-workforce-to-cut-costs-2016-02-12", "https://www.nasdaq.com/articles/new-strong-buy-stocks-for-february-11th-2016-02-11", "https://www.nasdaq.com/articles/dr.-reddys-q3-earnings-up-y-y-warning-letter-in-focus-2016-02-10", "https://www.nasdaq.com/articles/novo-nordisk-posts-in-line-q4-earnings-tops-revenues-2016-02-04", "https://www.nasdaq.com/articles/health-care-sector-update-10182016-atra-2016-10-18", "https://www.nasdaq.com/articles/qiagen-q4-and-2015-preliminary-results-dim-shares-tank-13-2016-01-13", "https://www.nasdaq.com/articles/halozyme-therapeutics-halo-in-focus%3A-stock-tumbles-16.7-2016-01-12", "https://www.nasdaq.com/articles/genomic-health-down-on-bleak-preliminary-q4-15-results-2016-01-11", "https://www.nasdaq.com/articles/myriad-genetics%3A-urologic-cancer-assays-positive-in-trials-2016-01-08", "https://www.nasdaq.com/articles/qiagen%3A-competition-currency-headwind-play-spoilsport-in-q3-2016-01-06", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra-jumps%3A-stock-moves-up-6-2015-12-21", "https://www.nasdaq.com/articles/atara-plunges-on-poor-results-from-phase-ii-pinta-745-study-2015-12-15", "https://www.nasdaq.com/articles/bio-techne-tech-q2-earnings-match-sales-beat-estimates-2016-02-03", "https://www.nasdaq.com/articles/qiagen-q4-and-2015-preliminary-results-dim-shares-tank-13-2016-01-13", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra-jumps%3A-stock-moves-up-10-2015-10-29", "https://www.nasdaq.com/articles/health-care-sector-update-10202015-immy-rxii-atra-2015-10-20", "https://www.nasdaq.com/articles/health-care-sector-update-07102015-atra-txmd-wx-2015-07-10", "https://www.nasdaq.com/articles/health-care-sector-update-07102015-atra-txmd-wx-2015-07-10-0", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra-crumbles%3A-stock-plunges-14.6-tale-of-the-tape-2015-07-02", "https://www.nasdaq.com/articles/why-atara-biotherapeutics-inc-shares-are-getting-mauled-today-2015-12-14", "https://www.nasdaq.com/articles/friday-sector-laggards-consumer-services-biotechnology-stocks-2015-02-27", "https://www.nasdaq.com/articles/seth-klarman-buys-stake-3-pharmaceutical-firms-2015-02-17", "https://www.nasdaq.com/articles/model-portfolio-review-february-16-2015-2015-02-16", "https://www.nasdaq.com/articles/health-care-sector-update-02102015-atrawmgibioc-2015-02-10", "https://www.nasdaq.com/articles/billion-dollar-biotech-fibrogen-sets-terms-124-million-ipo-2014-10-30", "https://www.nasdaq.com/articles/atara-biotherapeutics-prices-ipo-11-below-range-2014-10-16", "https://www.nasdaq.com/articles/atara-biotherapeutics-refiles-terms-75-million-ipo-2014-10-07", "https://www.nasdaq.com/articles/atara-biotherapeutics-atra-in-focus%3A-stock-rises-17.1-tale-of-the-tape-2015-06-16", "https://www.nasdaq.com/articles/14-us-ipos-planned-week-jul-21-2014-07-21", "https://www.nasdaq.com/articles/muscle-loss-biotech-atara-biotherapeutics-sets-terms-75-million-ipo-2014-07-10", "https://www.nasdaq.com/articles/us-ipo-pricing-recap-15-ipos-most-active-week-2007-66-ended-or-below-ipo-price-2014-08-01"], "Content": []}